The world's first mRNA vaccine against a deadly disease

Published Date: 15 Mar 2023

A world first: A research team from Tel Aviv University and the Israel Institute of Biology has developed an anti-mRNA drug that is 100% effective against a single type of virus.

Read Full News

Latest News

When Patients Arrive With AI Diagnoses

Patients increasingly come to visits with AI-generated ideas and online research, forcing doctors to balance information, uncertainty, and reassurance in real time.

When Patient Self-Scheduling Collides With Acute Care

Many health systems are giving patients the power to schedule appointments and procedures. What happens when that autonomy creates down-stream problems?

US FDA Approves Vera's Kidney Disease Drug

The U.S. Food and Drug Administration said on Tuesday it had approved Vera Therapeutics' drug to treat ⁠patients with a potentially life-threatening kidney...

Maternal RSV Shot Largely Safe, Except for Hypertension Risk

Vaccination against respiratory syncytial virus given late in pregnancy is not linked to adverse birth outcomes but is linked to a slightly increased risk for hypertensive disorders of pregnancy.

Hydrolyzed Rice Formula Effective in Cow’s Milk Allergy

Hydrolyzed rice formula serves as an additional nutritional option for managing cow’s milk protein allergy in infants.

Which Medications Increase Heat-Related Risk in Patients?

During periods of extreme heat, several drug classes can make patients more vulnerable to dehydration, heat exhaustion, and heatstroke.

Todays Updates

Real-World EV Plus Pembro Success Seen in Urothelial Cancer

A retrospective study evaluates outcomes associated with first-line enfortumab vedotin plus pembrolizumab vs gemcitabine plus cisplatin in patients with metastatic urothelial carcinoma.

Germline Variants Predict Lobular Breast Cancer Recurrence

For women with invasive lobular carcinoma, pathogenic variants in breast cancer risk genes predict high odds of early recurrence.

MRI Enhancement Predicts Breast Cancer in BRCA Carriers

Higher background parenchymal enhancement on breast MRI may signal greater risk among women who carry BRCA mutations.

Polatuzumab Vedotin Boosts Survival in Relapsed DLBCL

Patients with relapsed or refractory diffuse large B-cell lymphoma, who were ineligible for autologous stem cell transplant, were randomly assigned to receive Pola-R-GemOx or R-GemOx.

Todays Updates

Real-World EV Plus Pembro Success Seen in Urothelial Cancer

A retrospective study evaluates outcomes associated with first-line enfortumab vedotin plus pembrolizumab vs gemcitabine plus cisplatin in patients with metastatic urothelial carcinoma.

Germline Variants Predict Lobular Breast Cancer Recurrence

For women with invasive lobular carcinoma, pathogenic variants in breast cancer risk genes predict high odds of early recurrence.

MRI Enhancement Predicts Breast Cancer in BRCA Carriers

Higher background parenchymal enhancement on breast MRI may signal greater risk among women who carry BRCA mutations.

Polatuzumab Vedotin Boosts Survival in Relapsed DLBCL

Patients with relapsed or refractory diffuse large B-cell lymphoma, who were ineligible for autologous stem cell transplant, were randomly assigned to receive Pola-R-GemOx or R-GemOx.

Latest News

Patients increasingly come to visits with AI-generated ideas and online research, forcing doctors to balance information, uncertainty, and reassurance in real time.

Many health systems are giving patients the power to schedule appointments and procedures. What happens when that autonomy creates down-stream problems?

The U.S. Food and Drug Administration said on Tuesday it had approved Vera Therapeutics' drug to treat ⁠patients with a potentially life-threatening kidney...

Vaccination against respiratory syncytial virus given late in pregnancy is not linked to adverse birth outcomes but is linked to a slightly increased risk for hypertensive disorders of pregnancy.

Hydrolyzed rice formula serves as an additional nutritional option for managing cow’s milk protein allergy in infants.

During periods of extreme heat, several drug classes can make patients more vulnerable to dehydration, heat exhaustion, and heatstroke.

News All Time

I’ve Seen One Too Many E-Scooter Injuries in the Trauma Bay

It's time for stricter regulations

Dawn of Heart Muscle Patches to Address Lost Myocardium in Heart Failure

Early report on modular BioVAT patches in advanced stage C or D disease

Blood Markers to Direct Lung Cancer Screening; Name Change for PCOS

Also in TTHealthWatch: whole blood for trauma

Tenecteplase Unseats Low-Dose Alteplase Favored for Asian Patients

Japanese trial compared lytics for bridging before endovascular thrombectomy

Weight Loss and Atrial Fibrillation; DAPT After Bypass Surgery

Also in TTHealthWatch: at-home rehab after ICU stay

Cardiac Amyloidosis Diagnosis Gets a More Extensive AI Model

Clinical, lab parameters coupled with echo data in AI-ECM

Ebola Webinar June 4: Former USAID Official Discusses Flawed U.S. Response

Experts will review global health funding cuts and the consequences for disease prevention

Antibiotic Combo Approved for Multidrug-Resistant UTIs

Intravenous cefepime-zidebactam was significantly superior to meropenem in phase III trial

Spinal Cord Stimulation Restores Hand and Arm Mobility After Stroke

Preliminary research turns to a fully implantable system

CDC Sees 10,000 Ebola Deaths Among Possible Outbreak Scenarios

Despite the rapid spread, the risk to the U.S. remains low for now, agency says

Kids' Risk of Severe Respiratory Infection Rises With Comorbidity Count

Multiple preexisting conditions or hospital transfers pointed to trouble, but co-infection didn't

Mucus Thinners Yield Troubling Results for Ventilated ICU Patients

Signals of harm "arouse concern regarding the continued use" of carbocisteine, hypertonic saline

Sodium Bicarbonate Fails to Improve Kidney Outcomes in ICU

Rates of renal-replacement therapy, death were no better than with placebo

Medicare Pays for Programs That May Not Help After Serious Hospitalizations

Trial questions role of remote monitoring for patients with sepsis, severe respiratory infections

Cefazolin Proves Its Mettle for Methicillin-Susceptible Staph Infections

Findings should ease theoretical concerns about a cefazolin inoculum effect

Prone Positioning Not a Big Help for Infant Bronchiolitis

Randomized trial shows no definitive benefit for escalation to higher levels of ventilation

Recommended News For You

Combination therapy improves outcomes for advanced triple-negative breast cancer

No Seed Oil-Colon Cancer Link; Avoiding Prostate Biopsy; Top Cancer Advances

Stem Cell Selection Unneeded for SSc Transplant Therapy?

High Rate of Surgical Success in Complex NSCLC With Neoadjuvant Chemoimmunotherapy

In Biochemically Recurrent Nonmetastatic Prostate Cancer, Apalutamide Presents Its Argument.

Ranking of the Best US Hospitals for Psychiatric Care.

Why are so many young adults getting cancer?

Recommended Articles For You

Unlocking the Potential of CPK Levels: How to Maximize Your Health Benefits 

Healthy Hematopoietic Aging and Disease Avoidance: Mechanisms, Clinical Insights, and Future Directions 

Tertiary Lymphoid Structures in Cancer: Advancing Therapeutic Implications 

IGSF8: A Rising Star in Cancer Immunotherapy - Harnessing the Innate Immune System 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Taking Charge of Your Cancer Journey.

2.

Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin's Lymphoma

3.

Adipocytes in the bone marrow offer early indicators of the development of multiple myeloma from MGUS.

4.

Trump Issues Gag Order for CDC, FDA; Stalled Hearing for RFK Jr.; Sex After Cancer

5.

"We Caught It Early": Advantage or Disadvantage?

1.

How HLH is Revolutionizing Healthcare

2.

Unlocking the Unknown: A Comprehensive Guide to Stage 4 Vulvar Cancer

3.

The Importance of Understanding Your D-Dimer Levels: A Comprehensive Guide

4.

Personalized Cancer Vaccines: The Next Frontier in Precision Oncology

5.

Exploring the Unknown: Unveiling the Mysteries of GIST Tumors

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion

2.

Efficient Management of First line ALK-rearranged NSCLC - Part IV

3.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV

5.

Navigating the Complexities of Ph Negative ALL - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot